NCT04335279
- Conditions
- Anxiety Disorders, Behavior, COVID-19, +21 more
- Locations
-
- Sir Mortimer B. Davis Jewish General Hospital Montreal, Quebec, Canada
Clinical trial condition
Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.
NCT04335279
NCT00379431
NCT04752397
NCT02789670
NCT04300426
NCT04045743
NCT00074568
NCT03889509
NCT01670565
NCT04273386